RAD-SG: Adaptive radiation therapy with concurrent sacituzumab govitecan (SG) for bladder preservation in patients (pts) with muscle invasive bladder cancer (MIBC)

Category Primary study
Conference2025 ASCO Genitourinary Cancers Symposium
Year 2025
This article has no abstract
Epistemonikos ID: 2ab5fdf31a99cbd77ce8898629b521321b6d5d73
First added on: Jan 22, 2026